Skip to main content
. 2020 May 18;123(3):426–437. doi: 10.1038/s41416-020-0884-9

Fig. 5. miR-622 affects migration of breast cancer cell lines.

Fig. 5

Cell migration ability was determined in MDA-MB-231/miR-622 cells by wound healing (a) and by Transwell migration (b) assays. c Wound healing was also performed in MDA-MB-231 transfected with Anti-miR-622 respect to control cells (Anti-miR-Null). d Expression level of miR-622 was monitored, by q-RT-PCR, in MCF-7 cell line after stable transfection with miR-622 (left) or with Anti-miR-622 (right) plasmids respect to relative control cells (MCF-7/miR-Null or MCF7/Anti-miR-Null). e Cell migration ability was determined by Transwell migration assay also in MCF-7 after stable transfection. Data are presented as the mean ± S.D. *p < 0.05; **p < 0.01; ***p < 0.001.